Page last updated: 2024-08-17

diethylnitrosamine and sirolimus

diethylnitrosamine has been researched along with sirolimus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brilliant, KE; Cerretti, B; Claro, P; Clift, D; Gruppuso, PA; Hixson, DC; Mills, DR; Patel, A; Sanders, JA1
Aghajan, M; Hall, MN; Karin, M; Lee, JH; Nakagawa, H; Park, EJ; Seki, E; Shalapour, S; Taniguchi, K; Umemura, A; Valasek, MA1

Other Studies

2 other study(ies) available for diethylnitrosamine and sirolimus

ArticleYear
The inhibitory effect of rapamycin on the oval cell response and development of preneoplastic foci in the rat.
    Experimental and molecular pathology, 2012, Volume: 93, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Proliferation; Cell Shape; Cell Transformation, Neoplastic; Choline Deficiency; Diethylnitrosamine; Dual-Specificity Phosphatases; Ethionine; Fluorenes; Gene Expression Profiling; Hepatectomy; Hepatocytes; Liver Neoplasms, Experimental; Male; Mechanistic Target of Rapamycin Complex 1; Mitogen-Activated Protein Kinase Phosphatases; Multiprotein Complexes; Precancerous Conditions; Proteins; Rats; Sirolimus; TOR Serine-Threonine Kinases

2012
Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition.
    Cell metabolism, 2014, Jul-01, Volume: 20, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Animals; Carcinoma, Hepatocellular; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Diet, High-Fat; Diethylnitrosamine; DNA Damage; Fatty Liver; Glucose Tolerance Test; Hepatocytes; Humans; Inflammation; Interleukin-6; Liver; Liver Neoplasms; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Mitosis; Multiprotein Complexes; Reactive Oxygen Species; Regulatory-Associated Protein of mTOR; Sirolimus; STAT3 Transcription Factor; TOR Serine-Threonine Kinases

2014